Ftse Mib
37.820,79
0,77%
DAX
22.612,02
2,12%
S&P 500
6.113,88
1,02%
NASDAQ
19.905,94
1,30%
Bitcoin
96.229,72
-1,70%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Myovant Sciences Ltd (MYOV) Myovant Sciences Ltd (MYOV) Notizie

MYOV

Myovant Sciences (MYOV)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:MYOV
DataOraFonteTitoloSimboloCompagnia
20/03/202318:59Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NYSE:MYOVMyovant Sciences Ltd
17/03/202311:03Edgar (US Regulatory)Notice of Effectiveness (effect)NYSE:MYOVMyovant Sciences Ltd
10/03/202315:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:MYOVMyovant Sciences Ltd
10/03/202315:32Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NYSE:MYOVMyovant Sciences Ltd
10/03/202315:30Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NYSE:MYOVMyovant Sciences Ltd
10/03/202315:30Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NYSE:MYOVMyovant Sciences Ltd
10/03/202315:11Edgar (US Regulatory)Current Report Filing (8-k)NYSE:MYOVMyovant Sciences Ltd
16/02/202323:02Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NYSE:MYOVMyovant Sciences Ltd
16/02/202322:39Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NYSE:MYOVMyovant Sciences Ltd
14/02/202322:32Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:MYOVMyovant Sciences Ltd
09/02/202313:58Edgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:MYOVMyovant Sciences Ltd
06/02/202320:37Edgar (US Regulatory)Schedule 13g
(sc 13g/a)		NYSE:MYOVMyovant Sciences Ltd
26/01/202322:14Edgar (US Regulatory)Quarterly Report (10-q)NYSE:MYOVMyovant Sciences Ltd
26/01/202322:05GlobeNewswire Inc.Myovant Sciences Announces Corporate Updates and Financial Results for Third Fiscal Quarter 2022NYSE:MYOVMyovant Sciences Ltd
23/01/202322:47Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NYSE:MYOVMyovant Sciences Ltd
06/01/202322:10Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NYSE:MYOVMyovant Sciences Ltd
16/12/202214:00PR Newswire (US)MYOV SPECIAL ALERT: Julie & Holleman Investigates Potential Legal Claims Related to Take-Private Acquisition of Myovant SciencesNYSE:MYOVMyovant Sciences Ltd
09/12/202212:09Edgar (US Regulatory)Statement of Ownership: Private Transaction (sc 13e3)NYSE:MYOVMyovant Sciences Ltd
08/12/202223:00Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NYSE:MYOVMyovant Sciences Ltd
16/11/202222:45GlobeNewswire Inc.Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08NYSE:MYOVMyovant Sciences Ltd
16/11/202212:45GlobeNewswire Inc.Myovant Sciences Appoints Ann Tomlin as Senior Vice President of Human ResourcesNYSE:MYOVMyovant Sciences Ltd
26/10/202214:30GlobeNewswire Inc.Myovant Sciences Announces Corporate Updates and Financial Results for Second Fiscal Quarter 2022NYSE:MYOVMyovant Sciences Ltd
24/10/202222:30GlobeNewswire Inc.Myovant Sciences Cancels Second Quarter Earnings Conference CallNYSE:MYOVMyovant Sciences Ltd
24/10/202213:30TipRanksMyovant (MYOV) Stock Rising on Acquisition NewsNYSE:MYOVMyovant Sciences Ltd
24/10/202205:36GlobeNewswire Inc.Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive AgreementNYSE:MYOVMyovant Sciences Ltd
21/10/202223:16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:MYOVMyovant Sciences Ltd
14/10/202216:02GlobeNewswire Inc.CORRECTION -- Myovant Sciences, Inc.NYSE:MYOVMyovant Sciences Ltd
14/10/202212:45GlobeNewswire Inc.Myovant Sciences to Host Second Fiscal Quarter 2022 Earnings Conference Call at 5:00 p.m.NYSE:MYOVMyovant Sciences Ltd
03/10/202210:24TipRanksMyovant Sciences Rejects Sumitovant’s $2.4 Billion Acquisition OfferNYSE:MYOVMyovant Sciences Ltd
03/10/202201:36GlobeNewswire Inc.Myovant Sciences Special Committee of Board Confirms Receipt of Preliminary, Non-binding Proposal from Sumitovant Biopharma and Sumitomo Pharma to Acquire Remaining SharesNYSE:MYOVMyovant Sciences Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:MYOV

La tua Cronologia

BIT
S27876
Societe Generale Effekten
BIT
FAE
FAE Technology
BIT
WLD
ETF
BOV
M2PW34Q
Medical Properties
BIT
NSCIT1574150
Pfizer
BIT
5MIB
GraniteShares 5x Long MI...
BOV
P2AN34Q
Palo Alto Networks
AQSE
1PAS.GB
WisdomTree Multi Asset I...
BIT
F35805
Vontobel Financial Produ...
BIT
P1H9U3
BNP Paribas Issuance
BIT
P228M7
NLBNPIT228M7 20991231 18...
BIT
F12041
Vontobel Financial Produ...
BIT
3SAP
Graniteshares 3x Short A...
BIT
TSWE
ETF
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci